Stocktoria
Q32 Bio Inc. QTTB
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2018-03-28
Q32 Bio Inc. statistics & valuation
Market cap$223.3M
P / E7.5×
P / S4.2×
P / B5.3×
Net margin55.5%
Return on equity71.0%
FCF margin-62.4%
Return on capital33.5%
Graham number -13.2%$13.34
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($13.34); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating margin | 31.5% | — | 725.5% | -4154.6% | -282.4% | -4821.0% | -6599.2% | -1126.0% | — |
| Net margin | 55.5% | — | 808.0% | -156.0% | -281.9% | -4762.9% | -6237.5% | -1044.3% | — |
| FCF margin | -62.4% | — | 280.9% | -3583.1% | -330.1% | -3629.3% | -6794.2% | -1268.3% | — |
| Return on assets | 48.3% | -51.7% | -114.2% | -2.2% | -45.2% | -48.8% | -33.5% | -21.5% | -21.8% |
| Return on equity | 71.0% | -841.1% | 29.4% | 3.8% | -56.4% | -65.7% | -40.2% | -28.3% | 76.0% |
| Current ratio | 4.85 | 4.97 | 2.04 | 8.02 | 11.14 | 9.69 | 21.54 | 9.84 | 14.85 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.